Also found in: Dictionary, Acronyms.
A drug combination consisting of a dihydrofolate reductase inhibitor (trimethoprim) and a sulfonamide antibacterial drug (sulfamethoxazole). The drug combination is synergistic as the drugs interfere with two successive steps in the formation/utilization of folic acid by microorganisms. Used to treat many infectious diseases.
Farlex Partner Medical Dictionary © Farlex 2012
trimethoprim-sulfamethoxazoleBactrim®, Septra® A broad-spectrum combination antibacterial, formulated as a 1:20 ratio of T to S, which is effective in genitourinary, GI, and respiratory tract infections; it is the antibiotic of choice in PCP for which the failure rate of 5-20%; T-S is also effective against Salmonella, Shigella, Nocardia spp, H influenzae, Listeria monocytogenes, S pneumoniae, Isospora belli, and possibly Toxoplasma gondii; T-S is non-toxic in non-immunocompromised Pts; up to 60% of AIDS Pts have adverse effects–eg, ↑ LFTs, neutropenia, thrombocytopenia, erythematous maculo-papular rash, Stevens-Johnson syndrome, exfoliative dermatitis, N&V
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
An antibiotic used to treat and prevent PCP.
Mentioned in: Pneumocystis Pneumonia
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
tri·meth·o·prim-sul·fa·meth·ox·a·zole(TMP/SMX) (trī-meth'ō-prim sŭl'fă-meth-oks'ă-zōl)
Drug combination consisting of a dihydrofolate reductase inhibitor and a sulfonamide antibacterial drug; drug combination is synergistic as the drugs interfere with two successive steps in formation/use of folic acid by microorganisms. Used to treat many infectious diseases.
Medical Dictionary for the Dental Professions © Farlex 2012